by Sia | Jul 22, 2026 | News
The PoET® Multiscreen PCR kit allows simultaneous detection and differentiation of HCV, HBV, and HIV. PoET® Multiscreen has received IVDR certification, clearing the path for its commercial rollout. FRANKFURT, Germany — Addressing the critical need for enhanced blood...
by Sia | Mar 10, 2026 | News
Frankfurt, Germany – 2026-03-04 — GFE (Gesellschaft zur Forschung, Entwicklung und Distribution von Diagnostika im Blutspendewesen mbH), a recognized company specialized in NAT blood donor screening and Seegene Germany GmbH, the German subsidiary of Seegene Inc.,...
by Sia | Jun 20, 2024 | News
PoET® CMV is the first IVD assay on the market to screen donated blood for CMV by nucleic acid amplification technology (NAT) under the IVDR. Screening blood donors with the PoET® CMV test enables pathogen detection and reduces the risk of...
by Sia | Sep 13, 2023 | Events, News
We are glad to announce that GFE will attend 34th Regional Congress of the ISBT in Cape Town which will take place November 18 – 21, 2023. We are looking forward to your visit at our booth B78. All Information on...
by Sia | Sep 13, 2023 | Events, News
GFE will be participating in 56. Jahrestagung der DGTI from 20. – 22. September 2023 in Berlin. Come and meet our representatives at our Booth No. 14 in the exhibition area to learn more about our PoET® System. More Information can be found: here...
by Sia | May 18, 2022 | News
A new level of efficiency for WNV screening Frankfurt/Main – GFE today announced the launch of its PoET® WNV PCR kit. PoET® WNV is a CE-IVD marked test, based on real-time PCR technology, for the detection of West Nile virus RNA in human plasma samples. PoET® WNV is...
